Injection Anxiety and Pain in Men Using Intracavernosal Injection Therapy After Radical Pelvic Surgery
- 1 October 2013
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 10 (10) , 2559-2565
Abstract
Introduction Intracavernosal injection (ICI) therapy is a well‐recognized treatment strategy with high success rates for men with erectile dysfunction. Despite this, injection anxiety and pain related to injection are significant barriers to its use. Aims This study aims to examine injection anxiety and injection pain in patients using ICI. Methods Men starting ICI therapy post radical pelvic surgery completed questionnaires at initial visit, at each of the two ICI training sessions and at a 4‐month follow‐up visit. Main Outcome Measures Injection Anxiety Scale, Injection Pain Scale, Injection Reaction Inventory, and the Erectile Function Domain of the International Index of Erectile Function. Results Average age of the 68 men was 60 ± 8 years. At 4 months, the self‐reported frequency of ICI use was: 29% P < 0.001). At first injection, 65% reported high injection anxiety (≥5) and this significantly decreased to 42% (P = 0.003) at 4 months. Anxiety at first injection was negatively related to ICI frequency at 4 months (r = −0.23, P = 0.08). Mean injection pain score at first injection was low (2.2 ± 1.8, range 0–10) and 59% rated injection pain ≤2. Injection pain remained consistent across time periods. At first injection, injection anxiety (assessed prior to injection) was related to injection pain (r = 0.21, P = 0.04) and subjects (n = 21) who reported high injection anxiety (≥5) across time points, reported an increase in injection pain scores from first injection to 4 months (2.7 vs. 3.7, P = 0.05). Conclusions Although injection anxiety decreased with ICI use, mean injection anxiety remained at a moderate level (4.4) and 42% of men continued to report “high” injection anxiety at 4 months. While injection pain was low, injection anxiety and pain were related. These data suggest the need for a psychological intervention to help lower injection anxiety related to ICI. Nelson CJ, Hsiao W, Balk E, Narus J, Tal R, Bennett NE, and Mulhall JP. Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery. J Sex Med 2013;10:2559–2565.Keywords
This publication has 23 references indexed in Scilit:
- Sexual Rehabilitation and Penile Pain Associated with Intracavernous Alprostadil After Radical ProstatectomyThe Journal of Sexual Medicine, 2011
- Satisfaction Profiles in Men Using Intracavernosal Injection TherapyThe Journal of Sexual Medicine, 2011
- Patient-Reported Pain with Initial Intracavernosal InjectionThe Journal of Sexual Medicine, 2009
- Couple Satisfaction to Different Therapeutic Modalities for Organic Erectile DysfunctionThe Journal of Sexual Medicine, 2008
- The Use of an Erectogenic Pharmacotherapy Regimen Following Radical Prostatectomy Improves Recovery of Spontaneous Erectile FunctionThe Journal of Sexual Medicine, 2005
- Use of a Visual Analog Scale to Assess Pain of Injection with Intracavernous Injection TherapyThe Journal of Sexual Medicine, 2005
- Is Quality if Life Different for Men with Erectile Dysfunction and Prostate Cancer Compared to Men with Erectile Dysfunction Due to Other Causes? Results from the ExCEED Data BaseJournal of Urology, 2003
- Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile DysfunctionNew England Journal of Medicine, 1996
- High attrition rate with intracavernousinjection of prostaglandin E1 for impotencyUrology, 1994
- Why do so many people drop out from auto-injection therapy for impotence?Journal of Sex & Marital Therapy, 1989